Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Common Stock

Director Charles D. Baker reported the acquisition of 151 shares of UnitedHealth Group common stock on October 1, 2024, as part of director compensation.

Summary

• Charles D. Baker, a director of UnitedHealth Group, reported a transaction on October 1, 2024.
• Baker acquired 151 shares of UnitedHealth Group common stock at a price of $0 per share.
• These shares were received as deferred stock units, representing quarterly compensation for Baker's service as a director.
• The deferred stock units are immediately vested but must be retained until Baker completes his service on the Board.
• The report was filed on October 3, 2024, by Faraz A. Choudhry, Attorney-in-Fact for Charles D. Baker.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation, indicating alignment of interests between management and shareholders.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction reflects director compensation, aligning the director's interests with those of the shareholders.

Key Dates